Systemic Sclerosis Clinical Trials in Montreal, Quebec
4 recruitingMontreal, Quebec, Canada
Showing 1–4 of 4 trials
Recruiting
Phase 1
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Systemic SclerosisIdiopathic Inflammatory MyopathySystemic Lupus Erythematosus (With and Without Nephritis)
Allogene Therapeutics66 enrolled13 locationsNCT07085104
Recruiting
Phase 2
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Progressive Pulmonary FibrosisInterstitial Lung DiseasePulmonary Fibrosis+4 more
Avalyn Pharma Inc.375 enrolled152 locationsNCT06329401
Recruiting
Phase 2
Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease
Interstitial Lung DiseaseSystemic SclerosisSystemic Sclerosis With Lung Involvement
Centre hospitalier de l'Université de Montréal (CHUM)35 enrolled3 locationsNCT05785065
Recruiting
ILD-SARDs Registry and Biorepository
Interstitial Lung DiseaseRheumatic ArthritisSystemic Lupus Erythematosus+6 more
McGill University Health Centre/Research Institute of the McGill University Health Centre252 enrolled1 locationNCT05007340